<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=875423625897521&amp;ev=PageView&amp;noscript=1">

Sensing Savvy

End-Stage-Renal Disease’s Devastating Stats

Posted by Susan Eymann, MS on Mar 22, 2019

End-stage-renal-disease (ESRD) is devastating. In 2014, 118,000 people in the United States started treatment for ESRD, and 662,000 were living on chronic dialysis or with a end stage renal disease statskidney transplant.

While the number of ESRD incident cases plateaued in 2010, the number of ESRD-prevalent cases continues to rise by about 21,000 cases per year.

  • Men are 64% more likely than women to develop ESRD
  • African Americans are 3 times more likely than whites to develop ESRD
  • Hispanics are 35% more likely than non-Hispanics to develop ESRD
  • In U.S. adults ages 18 or older, the main reported causes of new cases of ESRD are diabetes and high blood pressure.

Most patients with ESRD begin renal replacement therapy with hemodialysis (In 2014, 87.9 percent). Almost 10 percent begin renal replacement with peritoneal dialysis, and 2.6 percent received a pre-emptive kidney transplant

At the beginning of 2015, 63.1 percent of all ESRD patients were receiving hemodialysis therapy, 6.9 percent were being treated with peritoneal dialysis, and 29.6 percent had a functioning kidney transplant. Among hemodialysis cases, 88.0 percent used in-center hemodialysis, and 1.8 percent used home hemodialysis.

New call-to-action

References:
https://www.cdc.gov/kidneydisease/pdf/kidney_factsheet.pdf

 

Topics: KDOQI

Healthcare Insights to Improve Results

Sensing Savvy provides you with the  information you need to stay up to date on the latest clinical news and trends, techniques, products and more. Start advancing your outcomes. Subscribe today.

Get Articles and Insights by Email

Recent Posts

StackAdapt Pixel